Form 4 for CRMD CorMedix Inc.
Accepted 2025-12-11 00:00:00 ET · period of report 2025-12-09 · accession 0001213900-25-120378 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-11 | 2025-12-09 | CRMD | Dillione Janet | Dir | M - OptEx | $7.82 | +34.0K | 67.5K | +102% | +$265.9K |
| D | 2025-12-11 | 2025-12-09 | CRMD | Dillione Janet | Dir | S - Sale+OE | $12.00 | -34.0K | 48.5K | -41% | -$408.0K |
| DM | 2025-12-11 | 2025-12-09 | CRMD | Dillione Janet | Dir | M - OptEx | $0.00 | -34.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-09 | M | A | 15,000 | $5.63 | 82,473 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-09 | M | A | 19,000 | $9.55 | 67,473 | D | — | — | |
| 3 | Common | Common Stock | 2025-12-09 | S | D | 34,000 | $12.00 | 48,473 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $12.00 to $12.02, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected |
| 4 | Derivative | Stock Option (Right to Buy Common Stock) | 2025-12-09 | M | D | 19,000 | $0.00 | 0 | D | $9.55 · — to 2026-02-21 | 19,000 Common Stock | (F2) These options were granted on 02/21/2016. These options are fully vested. |
| 5 | Derivative | Stock Option (Right to Buy Common Stock) | 2025-12-09 | M | D | 15,000 | $0.00 | 0 | D | $5.63 · — to 2030-02-25 | 15,000 Common Stock | (F3) These options were granted on 02/25/2020. These options are fully vested. |